Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination. [electronic resource]
Producer: 20210204Description: 993-1001 p. digitalISSN:- 1177-8881
- Antineoplastic Agents -- pharmacology
- Carcinoma, Hepatocellular -- drug therapy
- Cell Proliferation -- drug effects
- Deubiquitinating Enzyme CYLD -- metabolism
- Diarylheptanoids -- pharmacology
- Dose-Response Relationship, Drug
- Drug Screening Assays, Antitumor
- Humans
- Liver Neoplasms -- drug therapy
- Molecular Structure
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Structure-Activity Relationship
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.